ADDF Invests $1.18M to Standardize p-tau217 Blood Tests for Alzheimer’s Diagnosis

GSK Reports Positive Interim Results for DREAMM-7 Trial of Blenrep in Multiple Myeloma

Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test

MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299

Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus

FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories

Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care

Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer

Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation

Home
/
update
/
details

Oncare Secures $1 Million in Seed Funding Led by Huddle Ventures

NextEdge Admin

04 Oct 2024

2 min 5 sec

Oncare, a cancer care startup, has raised $1 million in a seed funding round led by Huddle Ventures, with additional participation from institutional investors like TRTL Ventures, Cloud Capital, and DeVC. The funds will support the company’s expansion to 10 new centers across Delhi NCR, Bangalore, and Jaipur over the next two years, alongside team growth and marketing efforts to increase awareness of its affordable cancer care services.

Founded in 2023 by Deepak Kumar and Amar Sneh, Oncare partners with 50-100 bedded hospitals to establish dedicated oncology wings, significantly reducing treatment costs by up to 40%. The startup aims to provide high-quality, affordable cancer treatment, offering a cost-effective alternative to expensive therapies, which often exceed Rs 10 lakh in corporate hospitals. In addition, Oncare provides on-call nursing support to help patients manage side effects and anxiety without frequent hospital visits.

Since launching in South Delhi, Oncare has guided over 2,500 patients in their treatment journeys and completed more than 500 treatment sessions. The need for accessible cancer care in India is critical, with cancer cases expected to rise from 1.39 million in 2020 to 1.57 million by 2025, according to annual Health of Nation report by Apollo Hospitals, as high costs and limited oncology centers continue to pose challenges.